Biotech

All Articles

AvenCell bags $112M to flick 'switchable' CAR-Ts in the facility

.AvenCell Therapeutics has secured $112 million in set B funds as the Novo Holdings-backed biotech f...

China- located biotech programs ph. 3 after seeing midstage eye records

.China-based Minghui Pharmaceutical has actually connected its thyroid eye condition therapy to a de...

Sangamo slashes opportunity to market for Fabry genetics therapy as FDA agrees to sped up approval package

.Sangamo Therapeutics has actually identified a quick way to market for its Fabry ailment prospect, ...

Otsuka's renal health condition medication enhances UPCR degrees in ph. 3 test

.Otsuka Pharmaceutical's renal ailment medicine has actually hit the key endpoint of a period 3 tria...

Roche scraps $120M tau possibility, returning civil liberties to UCB

.Roche has actually returned the civil liberties to UCB's anti-tau antibody bepranemab, leaving a $1...

Editas strengthens in vivo technique by means of $238M Genenvant deal

.Editas Medicines has actually signed a $238 million biobucks contract to integrate Genevant Scienti...

Combo end results, Vicodin skip as well as outstanding safety

.Tip has actually reported period 3 data on its own near-approval ache medication prospect suzetrigi...

Angelini markers $360M biobucks deal for ph. 1 brain ailment medicine

.Italy's Angelini Pharma has signed a $360 thousand biobucks pact centered on a phase 1-stage human ...

Sage gives up half of R&ampD staff as well as shakes up C-suite once again

.Sage Rehabs' latest try to diminish its own pipe and workforce will definitely view a third of the ...

With period 1 information, Mood has an eye on early-stage sac cancer cells

.With its own lead candidate in a period 3 trial for a rare eye cancer, Feeling Biosciences is seeki...